{"id":"bgc20-0582","safety":{"commonSideEffects":[{"rate":"null","effect":"Pneumonitis"},{"rate":"null","effect":"Hypothyroidism"},{"rate":"null","effect":"Hyperthyroidism"}]},"_chembl":{"chemblId":"CHEMBL5905663","moleculeType":null,"molecularWeight":"441.81"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BGC20-0582 works by binding to the PD-1 receptor, which is a protein on the surface of immune cells. This binding blocks the interaction between PD-1 and its ligands, leading to the activation of immune cells and the enhancement of anti-tumor responses.","oneSentence":"BGC20-0582 is a drug that targets the PD-1 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:23:23.926Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer, PD-L1 positive"},{"name":"Head and neck squamous cell carcinoma"}]},"trialDetails":[{"nctId":"NCT00528021","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2007-08","conditions":"Pediculus Humanus Capitis, Head Lice","enrollment":230}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"BGC20-0582","genericName":"BGC20-0582","companyName":"Boston Scientific Corporation","companyId":"boston-scientific-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BGC20-0582 is a drug that targets the PD-1 receptor. Used for Non-small cell lung cancer, PD-L1 positive, Head and neck squamous cell carcinoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}